methylprednisolone has been researched along with piroxicam in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Kagawa, K; Katoh, N; Yasuno, H | 1 |
| Asselin, I; Célestin, F; Entman, M; Goulet, M; Guérette, B; Huard, C; Roy, B; Roy, R; Skuk, D; Tardif, F; Tremblay, JP | 1 |
| Dommerich, S; Graumüller, S; Hoff, M; Ostwald, J | 1 |
| Bazzichi, L; Bombardieri, S; De Feo, F; Giacomelli, C; Giuliano, T; Grazzini, T; Mazzoni, A; Rossi, A; Scatena, F | 1 |
| Drew, SJ; Griffin, D; Karthikeyan, S; Kwong, HT; Parsons, N; Upadhyay, PK | 1 |
| Agacayak, KS; Gulsun, B; Gunes, N; Ilhan, O; Koparal, M | 1 |
| Çift, H; Mahiroğulları, M; Özkan, FÜ; Şeker, A; Tolu, S | 1 |
| Ak, D; Bulut, G; Laçin, B; Midi, A; Orak, MM; Purisa, S | 1 |
| Kayaoglu, HA; Ozkan, N; Ozsoy, S; Ozsoy, Z; Yaylak, F; Yenidogan, E | 1 |
1 review(s) available for methylprednisolone and piroxicam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for methylprednisolone and piroxicam
| Article | Year |
|---|---|
A double-blind randomised controlled study comparing subacromial injection of tenoxicam or methylprednisolone in patients with subacromial impingement.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Evidence-Based Medicine; Female; Humans; Injections, Intra-Articular; Lidocaine; Male; Methylprednisolone; Middle Aged; Piroxicam; Prospective Studies; Range of Motion, Articular; Rotator Cuff; Shoulder Impingement Syndrome; Tendinopathy; Treatment Outcome | 2010 |
A comparison of the effects of methylprednisolone and tenoxicam on pain, edema, and trismus after impacted lower third molar extraction.
Topics: Administration, Intravenous; Adult; Analysis of Variance; Anti-Inflammatory Agents; Edema; Humans; Methylprednisolone; Molar, Third; Pain; Pain Measurement; Piroxicam; Preoperative Care; Tooth Extraction; Trismus; Turkey | 2014 |
Comparison of subacromial tenoxicam and steroid injections in the treatment of impingement syndrome.
Topics: Adult; Aged; Anti-Inflammatory Agents; Female; Humans; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Pain Measurement; Piroxicam; Range of Motion, Articular; Rotator Cuff; Shoulder Impingement Syndrome; Surveys and Questionnaires; Tendinopathy | 2015 |
14 other study(ies) available for methylprednisolone and piroxicam
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Piroxicam induced Stevens-Johnson syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Japan; Methylprednisolone; Middle Aged; Osteoarthritis; Piroxicam; Stevens-Johnson Syndrome | 1995 |
Prevention by anti-LFA-1 of acute myoblast death following transplantation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Apoptosis; beta-Galactosidase; Biomarkers; Cell Adhesion; Cell Death; Cell Line, Transformed; Fluoresceins; Genes, Reporter; Graft Rejection; Immunosuppressive Agents; Inflammation; Interleukin-1; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, SCID; Muscle, Skeletal; Muscular Dystrophy, Animal; Naproxen; Necrosis; Neutrophils; Oxidative Stress; Peroxidase; Piroxicam; Radiation Chimera; Stem Cell Transplantation; Tacrolimus; Whole-Body Irradiation; Zymosan | 1997 |
[Influence of rhinologic usual and unusual drugs on fibroblasts from nasal polyps in cell culture].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Androstadienes; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Beclomethasone; Calcium Channel Blockers; Cells, Cultured; Culture Media; Diclofenac; Fibroblasts; Fluticasone; Glucocorticoids; Hematologic Agents; Humans; In Vitro Techniques; Mesalamine; Methylprednisolone; Mometasone Furoate; Muscarinic Agonists; Nasal Polyps; Pentoxifylline; Pilocarpine; Piroxicam; Prednisolone; Pregnadienediols; Time Factors; Timolol; Verapamil | 2003 |
Partial remission of refractory RA after Adacolumn cytapheresis: a case report.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Comorbidity; Cytapheresis; Female; Granulocytes; Hepatitis C, Chronic; Humans; Italy; Methylprednisolone; Monocytes; Piroxicam; Remission Induction; Treatment Outcome; Tuberculosis | 2008 |
Comparison of the effects of chronic intra-articular administration of tenoxicam, diclofenac, and methylprednisolone in healthy rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Diclofenac; Female; Injections, Intra-Articular; Knee Joint; Male; Methylprednisolone; Methylprednisolone Acetate; Osteoarthritis, Knee; Piroxicam; Rats; Rats, Wistar; Stomach; Synovial Membrane | 2015 |
The effect of methylprednisolone and tenoxicam on the protection of damage of the nerve physiomorphology caused by prolene mesh.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Electromyography; Fibrosis; Hernia, Inguinal; Inflammation; Male; Methylprednisolone; Piroxicam; Polypropylenes; Random Allocation; Rats, Wistar; Sciatic Nerve; Surgical Mesh | 2015 |